National HealthCare (NHC) is a Healthcare company in the Medical Care Facilities industry. It has a market capitalization of $3.27B, a trailing price-to-earnings ratio of 66.9 and a free-cash-flow yield of 4.5%. Over the most recent reported fiscal year, revenue grew 16.9% and free cash flow per share grew 85.9%. Nama's AI scorecard rates it Hold, 5.5 out of 10. On 12-month momentum it ranks in the leading band of its market.
AI scorecard
Hold · 5.5/10
The sections balance. As of Nov 7, 2026.
Momentum
Leading · +77.0% over 12 months ex. last
Top 20% of its market on the past year's steady rise.
Shariah screen
Shariah Compliant
Passes our debt, cash and income screen; not a scholar's ruling.
Off its high
-15.8%
How far the last close sits under the highest price of the past five years.
Nama's AI scorecard currently rates National HealthCare Hold (5.5 out of 10), a call computed from its profitability, cash generation, growth, valuation and balance sheet. It is a research reading, not investment advice.
What is NHC's P/E ratio?
National HealthCare trades at a trailing price-to-earnings ratio of 66.9.
Is NHC Shariah compliant?
Nama's AAOIFI-style screen reads National HealthCare as Shariah Compliant. Passes our debt, cash and income screen; not a scholar's ruling.
Does NHC pay a dividend?
Yes — National HealthCare's dividend yield is 1.3%.